Articles

Every flower needs a STEM

It doesn’t take a very elegant sensor to detect the current general malaise. Those of us who are old enough to have suffered a half-dozen such cycles know that we’ve come out of them by focusing on and delivering on innovation.
Written byPeter Kissinger
| 3 min read

It doesn't take a very elegant sensor to detect the current general malaise. Those of us who are old enough to have suffered a half-dozen such cycles know that we've come out of them by focusing on and delivering on innovation. Today, we have been closing R&D centers and creating unproductive heat by assessing blame. The challenges of delivering airplanes on time, drugs that are perfectly safe and investment banks that can be trusted have become entertainment. It's hard to find serious problem solvers among our politicians or journalists. It's hard to find people who will sit down and consider alternatives without being personally offended, shouting or even walking away. As I've commented before, hype in life science businesses and academia have accelerated to the point that most pronouncements engender cynicism.

To continue reading this article, subscribe for FREE toDrug Discovery News Logo

Subscribe today to keep up to date with the latest advancements and discoveries in drug development achieved by scientists in pharma, biotech, non-profit, academic, clinical, and government labs.

Add Drug Discovery News as a preferred source on Google

Add Drug Discovery News as a preferred Google source to see more of our trusted coverage.

About the Author

Here are some related topics that may interest you:

Published In

Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Illustration of multiple three-dimensional patient-derived organoids suspended against a dark blue background, representing tumor models used in precision oncology research.
By combining organoid biology with precision automation, researchers developed a miniaturized organoid screening platform that could help speed personalized cancer treatment testing.
Illustration of multiple three-dimensional patient-derived organoids suspended against a dark blue background, representing tumor models used in precision oncology research.
By combining organoid biology with precision automation, researchers developed a miniaturized organoid screening platform that could help speed personalized cancer treatment testing.
3D illustration of a membrane protein embedded within a lipid nanodisc, representing a native-like environment used for membrane protein stabilization and characterization.
Mass photometry supports membrane protein characterization by providing rapid insights into sample composition, purity, and molecular assembly.
Drug Discovery News December 2025 Issue
Latest IssueVolume 21 • Issue 4 • December 2025

December 2025

December 2025 Issue

Explore this issue